RHHBY ROCHE HOLDING AG
- 35.730
- +0.320+0.90%
- 35.740
- +0.010+0.03%
ROCHE HOLDING AG News
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
Barclays Remains a Hold on Roche Holding AG (RHHVF)
Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com
Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details
Roche Holding AG (RHHVF) Receives a Sell From Goldman Sachs
Roche Anti-TIGIT Therapy Fails to Extend Survival in Late-stage Lung Cancer Trial
Poseida Therapeutics to Be Acquired by Roche Holdings in $1.5 Billion Deal
Roche's Lung-Cancer Trial Failure Doesn't Surprise -- Market Talk
Roche's Genentech Provides Update On SKYSCRAPER-01 Phase III Study In PD-L1-High NSCLC Patients
Poseida Therapeutics To Be Acquired BB Roche In $1.5B Deal, Stockholders To Receive Up To $13/ Share In Cash
Roche: Transaction Is Expected Closed in 1Q 2025
Roche: Stockholders Would Also Get a Non-Tradeable Contingent Value Right
Roche's Combination Formulation for Non-small Cell Lung Cancer Falls Short of Primary Endpoint
Roche: Agreement Represents a Total Equity Value of Approximately $1.0B
Roche: Agreement Includes Cell Therapy Candidates and Related Platform Technologies
Press Release: Poseida Therapeutics, Inc. Announces Agreement to Be Acquired by Roche Holdings, Inc.
Roche Holding AG Falls Monday
Roche Wins FDA Approval For The First Diagnostic To Identify Biliary Tract Cancer Patients For HER2-Targeted Therapy With ZIIHERA
Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735
Analysis
Price Target
No Data
No Data
